Published in Eur J Gastroenterol Hepatol on September 01, 1996
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut (2001) 3.45
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut (2001) 1.46
Diagnosis of hepatocellular carcinoma. World J Gastroenterol (2009) 1.39
Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. J Transl Med (2007) 1.05
Recent developments in the first detection of hepatocellular carcinoma. Clin Biochem Rev (2005) 0.93
Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma? PLoS One (2014) 0.79
An update of biochemical markers of hepatocellular carcinoma. Int J Health Sci (Qassim) (2016) 0.79
Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence. World J Surg (2004) 0.78
Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget (2016) 0.75
Should methionine be added to every paracetamol tablet? BMJ (1997) 3.33
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Hepatotoxicity of herbal remedies. BMJ (1989) 2.37
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33
Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet (1999) 1.89
Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2010) 1.87
Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol (1995) 1.84
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
Hepatic encephalopathy and ascites. Lancet (1997) 1.57
Randomised clinical study: comparison of acceptability, patient tolerance, cardiac stress and endoscopic views in transnasal and transoral endoscopy under local anaesthetic. Aliment Pharmacol Ther (2014) 1.54
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther (2003) 1.49
TIPSS 10 years on. Gut (2000) 1.48
Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol (1997) 1.48
The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation (2000) 1.47
Hepatotoxicity of sodium stibogluconate in leishmaniasis. Lancet (1993) 1.42
Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology (1995) 1.40
The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther (2012) 1.40
The hands in alcoholic liver disease. Am J Gastroenterol (1991) 1.39
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab (2000) 1.38
Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther (2008) 1.38
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut (2000) 1.20
Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology (2000) 1.14
Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol (1996) 1.12
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Aliment Pharmacol Ther (2012) 1.10
Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut (1997) 1.09
The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut (2008) 1.08
Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience. Clin Radiol (1992) 1.07
Review article: the current management of acute liver failure. Aliment Pharmacol Ther (2009) 1.06
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. Cardiovasc Res (1998) 1.04
The influence of captopril, the nitrates and propranolol on apparent liver blood flow. Br J Clin Pharmacol (1985) 1.04
Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Gut (2003) 1.04
Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM (1998) 1.03
Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis. Hepatology (2001) 1.01
Age, anemia, and obesity-associated oxygen desaturation during upper gastrointestinal endoscopy. Gastrointest Endosc (1993) 1.01
Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl (2000) 1.01
Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl (2001) 1.01
A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther (1997) 1.00
Review article: current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther (2001) 1.00
Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther (2002) 1.00
Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. Carcinogenesis (1988) 1.00
Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal'. QJM (2002) 0.99
Evidence of hydrogen ion secretion from the human gall bladder in vitro. Gut (1992) 0.99
Transjugular intrahepatic portosystemic stent-shunt (TIPSS): long-term follow-up. QJM (1994) 0.98
Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology (1989) 0.98
Review article: the management of acute liver failure. Aliment Pharmacol Ther (1998) 0.97
Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet (1995) 0.96
Review article: recent advances in the management of bleeding gastric varices. Aliment Pharmacol Ther (2006) 0.96
Prevalence, incidence, and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors. J Infect Dis (1998) 0.95
Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. Aliment Pharmacol Ther (2000) 0.95
Association between chronic hepatitis C infection and hepatocellular carcinoma. Lancet (1995) 0.94
Review article: quantitative tests of liver function. Aliment Pharmacol Ther (1995) 0.94
A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation. Qual Life Res (2000) 0.94
The simulated microgravity environment maintains key metabolic functions and promotes aggregation of primary porcine hepatocytes. Biochim Biophys Acta (2001) 0.94
Serum hyaluronan--a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol (2000) 0.93
The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users. Eur J Gastroenterol Hepatol (1998) 0.93
A passive haemagglutination (TRC) inhibitor in thyrotoxic serum. Clin Endocrinol (Oxf) (1979) 0.93
Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy. Aliment Pharmacol Ther (2014) 0.92
The liver in typhoid fever: always affected, not just a complication. Am J Gastroenterol (1991) 0.92
The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. Clin Radiol (2011) 0.92
Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet (1991) 0.91
Plasma glutathione S-transferase measurements in patients with alcoholic cirrhosis. Clin Chim Acta (1987) 0.91
Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis. J Hepatol (1999) 0.90
Intrahepatic proliferation of 'naive' and 'memory' T cells during liver allograft rejection: primary immune response within the allograft. FASEB J (1998) 0.90
Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites. Gut (2005) 0.89
Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland. Lancet (2001) 0.89
Glutathione S-transferase in human bile. Clin Chim Acta (1989) 0.89
Autonomic function in cirrhosis assessed by cardiovascular reflex tests and 24-hour heart rate variability. Am J Gastroenterol (1994) 0.88
Interferon treatment for chronic hepatitis C infection in hemophiliacs--influence of virus load, genotype, and liver pathology on response. Blood (1996) 0.88
Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1995) 0.88
Glutathione S-transferases in alcoholic liver disease. Gut (1990) 0.87
Transjugular intrahepatic portosystemic stent-shunt (TIPSS) occlusion and the role of biliary venous fistulae. J Hepatol (1996) 0.87
The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man. Am J Gastroenterol (1999) 0.87
In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis. Pharmacol Ther (1997) 0.86
Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices. Hepatology (1989) 0.86
A new method for semi-automated quantitation of E-rosettes using a particle size analyser (Coulter Channelyzer). J Immunol Methods (1979) 0.86
The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis. J Hepatol (1995) 0.86
Liver biopsy bleeding time: an unpredictable event. J Gastroenterol Hepatol (1994) 0.86
Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther (2010) 0.86
The effect of strenuous physical exercise on circulating blood lymphocytes and serum cortisol levels. J Clin Lab Immunol (1981) 0.85
Transjugular intrahepatic portasystemic stent-shunt in the treatment of variceal haemorrhage. Br J Surg (1995) 0.85
Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis. J Hepatol (1996) 0.85
The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection. Liver Transpl Surg (1998) 0.85
Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma. Eur J Gastroenterol Hepatol (2000) 0.85
Laparoscopy and histology in the diagnosis of chronic liver disease. QJM (1995) 0.85
Comparison of the Glasgow alcoholic hepatitis score and the ABIC score for the assessment of alcoholic hepatitis. Am J Gastroenterol (2010) 0.85
Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. J Hepatol (1999) 0.85
EUS-assisted thrombin injection for ectopic bleeding varices--a case report and review of the literature. QJM (2011) 0.85
The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland. Clin Exp Dermatol (1996) 0.84
Contractile response of isolated human hepatic arteries to alpha-adrenoceptor agonists is not impaired in patients with cirrhosis. Clin Sci (Lond) (1998) 0.84
Alcoholic hepatitis: from pathogenesis to treatment. Curr Med Res Opin (2005) 0.84
Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. Liver Transpl Surg (1997) 0.84